Skip to main content

Table 4 Clinical outcomes of fresh embryo transfer

From: Effects of SARS-CoV-2 infection during IVF treatment on embryo morphokinetics and pregnancy outcomes after fresh transfer: a prospective cohort study

 

Both positive

(n = 21)

Female positive

(n = 49)

Male positive

(n = 16)

Both negative

(n = 104)

P-value

Stage of embryos transferred, n (%)

    

0.470

 Cleavage

5 (23.8)

6 (12.2)

3 (18.8)

13 (12.5)

 

 Blastocyst

16 (76.2)

43 (87.8)

13 (81.3)

91 (87.5)

 

No. of embryos transferred, n (%)

    

0.581

 Single

16 (76.2)

43 (87.8)

13 (81.3)

89 (85.6)

 

 Double

5 (23.8)

6 (12.2)

3 (18.8)

15 (14.4)

 

Endometrial thickness on trigger day (mm)

11.8 ± 3.4

10.4 ± 3.0

11.8 ± 3.2

11.1 ± 2.6

0.146

Biochemical pregnancy rate, n (%)

18 (85.7)

40 (81.6)

12 (75.0)

92 (88.5)

0.387

Implantation rate, n/N (%)

20/26 (76.9)

36/55 (65.5)

11/19 (57.9)

82/119 (68.9)

0.561

Clinical pregnancy rate, n (%)

17 (81.0)

34 (69.4)

11 (68.8)

80 (76.9)

0.628

Early miscarriage rate, n/N (%)

2/17 (11.8)

3/34 (8.8)

1/11 (9.1)

4/80 (5.0)

0.484

Ongoing pregnancy rate, n (%)

15 (71.4)

31 (63.3)

10 (62.5)

76 (73.1)

0.587

Live birth rate, n (%)

14 (66.7)

28 (57.1)

7 (43.8)

67 (64.4)

0.376

  1. Data are presented as mean ± SD or number (percentage)